Yuhan Corp.
Yuhan Corporation manufactures and sells prescription drugs, over-the-counter drugs, veterinary drugs, and household goods in South Korea and internationally. It also manufactures and sells animal feed and health functional food. The company was founded in 1926 and is headquartered in Seoul, South Korea.
Yuhan Corp. (000100) - Total Assets
Latest total assets as of September 2025: ₩3.05 Trillion KRW
Based on the latest financial reports, Yuhan Corp. (000100) holds total assets worth ₩3.05 Trillion KRW as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Yuhan Corp. - Total Assets Trend (2000–2024)
This chart illustrates how Yuhan Corp.’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Yuhan Corp. - Asset Composition Analysis
Current Asset Composition (December 2024)
Yuhan Corp.'s total assets of ₩3.05 Trillion consist of 46.2% current assets and 53.8% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 10.4% |
| Accounts Receivable | ₩609.13 Billion | 20.7% |
| Inventory | ₩343.16 Billion | 11.7% |
| Property, Plant & Equipment | ₩0.00 | 0.0% |
| Intangible Assets | ₩169.68 Billion | 5.8% |
| Goodwill | ₩115.07 Billion | 3.9% |
Asset Composition Trend (2000–2024)
This chart illustrates how Yuhan Corp.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Yuhan Corp.'s current assets represent 46.2% of total assets in 2024, an increase from 0.0% in 2000.
- Cash Position: Cash and equivalents constituted 10.4% of total assets in 2024, up from 5.0% in 2000.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 8.0% of total assets, an increase from 0.0% in 2000.
- Asset Diversification: The largest asset category is accounts receivable at 20.7% of total assets.
Yuhan Corp. Competitors by Total Assets
Key competitors of Yuhan Corp. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
|
Yuyu Pharma Inc
KO:000227
|
Korea | ₩202.42 Billion |
Yuhan Corp. - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Yuhan Corp. generates 0.70x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Yuhan Corp. generates $ 2.40 in net profit.
Yuhan Corp. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.14 | 2.30 | 3.13 |
| Quick Ratio | 1.65 | 1.79 | 2.47 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ₩777.19 Billion | ₩ 739.11 Billion | ₩ 813.34 Billion |
Yuhan Corp. - Advanced Valuation Insights
This section examines the relationship between Yuhan Corp.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.46 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 4.6% |
| Total Assets | ₩2.94 Trillion |
| Market Capitalization | $4.21 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Yuhan Corp.'s assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Yuhan Corp.'s assets grew by 4.6% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Yuhan Corp. (2000–2024)
The table below shows the annual total assets of Yuhan Corp. from 2000 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ₩2.94 Trillion | +4.61% |
| 2023-12-31 | ₩2.81 Trillion | +13.73% |
| 2022-12-31 | ₩2.47 Trillion | +0.36% |
| 2021-12-31 | ₩2.46 Trillion | +2.94% |
| 2020-12-31 | ₩2.39 Trillion | +13.05% |
| 2019-12-31 | ₩2.12 Trillion | -2.60% |
| 2018-12-31 | ₩2.17 Trillion | +3.78% |
| 2017-12-31 | ₩2.09 Trillion | +2.38% |
| 2016-12-31 | ₩2.05 Trillion | +8.81% |
| 2015-12-31 | ₩1.88 Trillion | +16.36% |
| 2014-12-31 | ₩1.62 Trillion | +6.74% |
| 2013-12-31 | ₩1.51 Trillion | +7.90% |
| 2012-12-31 | ₩1.40 Trillion | +6.77% |
| 2011-12-31 | ₩1.31 Trillion | +4.66% |
| 2010-12-31 | ₩1.26 Trillion | +10.64% |
| 2009-12-31 | ₩1.13 Trillion | +9.23% |
| 2008-12-31 | ₩1.04 Trillion | +4.18% |
| 2007-12-31 | ₩997.19 Billion | +5.93% |
| 2006-12-31 | ₩941.40 Billion | +4.76% |
| 2005-12-31 | ₩898.67 Billion | +17.49% |
| 2004-12-31 | ₩764.90 Billion | +15.97% |
| 2003-12-31 | ₩659.58 Billion | +4.52% |
| 2002-12-31 | ₩631.04 Billion | +8.10% |
| 2001-12-31 | ₩583.76 Billion | +4.97% |
| 2000-12-31 | ₩556.14 Billion | -- |